BACKGROUND: Monitoring time trends in the incidence of childhood leukaemias and lymphomas requires efficient and continuous data collecting systems. In countries without official cancer registries, such as Greece, ad hoc nationwide registration of incident childhood leukaemias and lymphomas could help elucidate the underlying aetiology and monitor socioeconomic differentials in health care delivery. METHODS: We registered all cases and produced age, gender, type and immunophenotype specific figures and overall crude and age adjusted annual incidence rates and secular trends for 863 leukaemia and 311 lymphoma incident cases diagnosed in children <15 years of age across Greece during 1996-2006, namely the first 11 years of the Nationwide Registry for Childhood Hematological Malignancies. RESULTS: The epidemiological profiles of leukaemias/lymphomas in Greece are similar to those in industrialised countries. No secular trends are observed for either malignancy during the studied period. However, the calculated incidence for leukaemia (46.60 cases per 1 million children annually) is among the highest in the EU-27 (19% higher than average; p<0.001), whereas that for lymphoma (16.8 cases per 1 million children annually) is around the EU-27 average. CONCLUSIONS: Minimal secular changes in childhood leukaemias/lymphomas have been noted recently in the EU-27, which cannot be easily explained in countries with small populations. Therefore, centralised EU databases such as the Automated Childhood Cancer Information System (ACCIS) should be enlarged to generate sufficient statistical power for monitoring time trends. It would be interesting to explore whether different lifestyle patterns across the EU might be responsible for the observed excess leukaemia incidence in countries such as Greece.
BACKGROUND: Monitoring time trends in the incidence of childhood leukaemias and lymphomas requires efficient and continuous data collecting systems. In countries without official cancer registries, such as Greece, ad hoc nationwide registration of incident childhood leukaemias and lymphomas could help elucidate the underlying aetiology and monitor socioeconomic differentials in health care delivery. METHODS: We registered all cases and produced age, gender, type and immunophenotype specific figures and overall crude and age adjusted annual incidence rates and secular trends for 863 leukaemia and 311 lymphoma incident cases diagnosed in children <15 years of age across Greece during 1996-2006, namely the first 11 years of the Nationwide Registry for Childhood Hematological Malignancies. RESULTS: The epidemiological profiles of leukaemias/lymphomas in Greece are similar to those in industrialised countries. No secular trends are observed for either malignancy during the studied period. However, the calculated incidence for leukaemia (46.60 cases per 1 million children annually) is among the highest in the EU-27 (19% higher than average; p<0.001), whereas that for lymphoma (16.8 cases per 1 million children annually) is around the EU-27 average. CONCLUSIONS: Minimal secular changes in childhood leukaemias/lymphomas have been noted recently in the EU-27, which cannot be easily explained in countries with small populations. Therefore, centralised EU databases such as the Automated Childhood Cancer Information System (ACCIS) should be enlarged to generate sufficient statistical power for monitoring time trends. It would be interesting to explore whether different lifestyle patterns across the EU might be responsible for the observed excess leukaemia incidence in countries such as Greece.
Authors: Amy Hagopian; Riyadh Lafta; Jenan Hassan; Scott Davis; Dana Mirick; Tim Takaro Journal: Am J Public Health Date: 2010-02-18 Impact factor: 9.308
Authors: Jérémie Rudant; Tracy Lightfoot; Kevin Y Urayama; Eleni Petridou; John D Dockerty; Corrado Magnani; Elizabeth Milne; Logan G Spector; Lesley J Ashton; Nikolaos Dessypris; Alice Y Kang; Margaret Miller; Roberto Rondelli; Jill Simpson; Eftichia Stiakaki; Laurent Orsi; Eve Roman; Catherine Metayer; Claire Infante-Rivard; Jacqueline Clavel Journal: Am J Epidemiol Date: 2015-03-01 Impact factor: 4.897
Authors: Despoina N Maritsi; Helen V Kosmidis; Varvara Douna; Joanne Traeger-Synodinos; Maria N Tsolia; Lydia Kossiva Journal: Int J Hematol Date: 2013-10-05 Impact factor: 2.490
Authors: Eleni Th Petridou; Theodoros N Sergentanis; Nick Dessypris; Iris T Vlachantoni; Sofia Tseleni-Balafouta; Apostolos Pourtsidis; Maria Moschovi; Sofia Polychronopoulou; Fani Athanasiadou-Piperopoulou; Maria Kalmanti; Christos S Mantzoros Journal: J Clin Oncol Date: 2009-09-08 Impact factor: 44.544
Authors: Laurent Orsi; Corrado Magnani; Eleni T Petridou; John D Dockerty; Catherine Metayer; Elizabeth Milne; Helen D Bailey; Nick Dessypris; Alice Y Kang; Catharina Wesseling; Claire Infante-Rivard; Victor Wünsch-Filho; Ana M Mora; Logan G Spector; Jacqueline Clavel Journal: Cancer Med Date: 2018-04-16 Impact factor: 4.452
Authors: Catherine Metayer; Elizabeth Milne; Jacqueline Clavel; Claire Infante-Rivard; Eleni Petridou; Malcolm Taylor; Joachim Schüz; Logan G Spector; John D Dockerty; Corrado Magnani; Maria S Pombo-de-Oliveira; Daniel Sinnett; Michael Murphy; Eve Roman; Patricia Monge; Sameera Ezzat; Beth A Mueller; Michael E Scheurer; Bruce K Armstrong; Jill Birch; Peter Kaatsch; Sergio Koifman; Tracy Lightfoot; Parveen Bhatti; Melissa L Bondy; Jérémie Rudant; Kate O'Neill; Lucia Miligi; Nick Dessypris; Alice Y Kang; Patricia A Buffler Journal: Cancer Epidemiol Date: 2013-02-09 Impact factor: 2.984